14.70
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché RNAZ Giù?
Forum
Previsione
Frazionamento azionario
Transcode Therapeutics Inc Borsa (RNAZ) Ultime notizie
Does TransCode Therapeutics Inc. fit your quant trading modelJuly 2025 WrapUp & Accurate Trade Setup Notifications - newser.com
CK Life Merges Polynoma with TransCode in $125M DealNews and Statistics - IndexBox
CK Life Sciences sees low geopolitical risks in a US merger - The Standard (HK)
Multi asset correlation models including TransCode Therapeutics Inc.July 2025 Highlights & Risk Managed Investment Strategies - newser.com
TransCode Therapeutics (NASDAQ:RNAZ) Earns “Sell (E+)” Rating from Weiss Ratings - Defense World
Critical Analysis: Century Therapeutics (NASDAQ:IPSC) and TransCode Therapeutics (NASDAQ:RNAZ) - Defense World
CKLIFE SCIENCES Estimates Completion of TransCode Preferred Stock Conversion in 6 Mths at Earliest - AASTOCKS.com
How hedge fund analytics apply to TransCode Therapeutics Inc. stockJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com
CK Life unit merges with TransCode as Li Ka-shing firm eyes anticancer drugs - South China Morning Post
TransCode Therapeutics Acquires Polynoma, Secures $25 Million Investment to Advance Oncology Pipeline - citybuzz
TransCode Therapeutics, Inc. (RNAZ) Stock :Soars as $25M Investment and Polynoma Acquisition Ignite Growth Prospects - parameter.io
TransCode Therapeutics To Acquire Polynoma; $25M Financing By a Subsidiary Of CK Life Sciences - citybiz
TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout - Benzinga
Transcode announces the acquisition of Polynoma and a $25 mln financing by subsidiary of CK Life Sciences - MarketScreener
TransCode Therapeutics stock soars after Polynoma acquisition By Investing.com - Investing.com Canada
TransCode Acquires Polynoma, Secures $25M Strategic Investment | RNAZ Stock News - Stock Titan
TransCode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset - Stocktwits
Chart based exit strategy for TransCode Therapeutics Inc.2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Strategies to average down on TransCode Therapeutics Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com
TransCode Therapeutics Amends Patent License Agreement - TipRanks
TransCode Therapeutics (NASDAQ:RNAZ) Trading Down 1.5% – What’s Next? - Defense World
Will TransCode Therapeutics Inc. stock go up soonMarket Activity Report & Growth Oriented Trade Recommendations - newser.com
Is TransCode Therapeutics Inc. stock bottoming outJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - newser.com
TransCode Therapeutics Passes Key Proposals at Annual Meeting - MSN
Developing predictive dashboards with TransCode Therapeutics Inc. dataMarket Sentiment Review & Safe Capital Allocation Plans - newser.com
TransCode Therapeutics Inc Stock Analysis and ForecastSupport Level Holds & Our Picks = Your Future Gains - earlytimes.in
What analysts say about TransCode Therapeutics Inc stockShort-Term Trading Alerts & Build a Smarter Portfolio Right Now - earlytimes.in
A activity2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
What to expect from CPSH in the next 30 daysWatch List & High Accuracy Swing Entry Alerts - newser.com
Is Mineralys Therapeutics Inc. stock poised for growthJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
NGVT stock trend outlook and recovery pathMarket Movement Recap & Safe Entry Momentum Tips - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):